The assessment and management of pain in cirrhosis
- PMID: 29552453
- PMCID: PMC5849403
- DOI: 10.1007/s11901-018-0389-7
The assessment and management of pain in cirrhosis
Abstract
Purpose of review: The treatment of pain in patients with cirrhosis is complicated by unpredictable hepatic drug metabolism and a higher risk of adverse drug reactions. We aimed to conduct a scoping review regarding pain management in cirrhosis.
Recent findings: Despite the high prevalence of pain in patients with cirrhosis, there is little literature to guide the management of pain in this population. Complex pain syndromes and disease-specific pain etiologies exist are common in patients with cirrhosis. There are numerous contraindications and limitations when considering pharmacotherapy for analgesia in cirrhosis, specifically with non-steroidal anti-inflammatory drugs (NSAIDS) and opioid medications. Non-pharmacologic therapies for pain have not been specifically assessed in this population.
Summary: As with other populations, a multi-dimensional treatment approach to pain with a focus on physical, behavioral, procedural and pharmacologic treatment is recommended when caring for patients with cirrhosis and pain. However, more research is needed to evaluate opioid-sparing and non-pharmacologic analgesia in this population.
Keywords: analgesia; chronic liver disease; cirrhosis; pain.
Conflict of interest statement
Conflict of Interest Shari Rogal reports grants from Gilead Sciences, outside of the submitted work. Matthew Klinge, Tami Coppler, Jane M. Liebschutz, Mohannad Dugum, Ajay Wassan, and Andrea DiMartini each declare no conflicts of interest. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors
Figures
Similar articles
-
Perioperative Opioid-sparing Strategies: Utility of Conventional NSAIDs in Adults.Clin Ther. 2019 Dec;41(12):2612-2628. doi: 10.1016/j.clinthera.2019.10.002. Epub 2019 Nov 14. Clin Ther. 2019. PMID: 31733939 Review.
-
Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD012537. doi: 10.1002/14651858.CD012537.pub2. Cochrane Database Syst Rev. 2017. PMID: 28770976 Free PMC article. Review.
-
Pharmacotherapy for Spine-Related Pain in Older Adults.Drugs Aging. 2022 Jul;39(7):523-550. doi: 10.1007/s40266-022-00946-x. Epub 2022 Jun 27. Drugs Aging. 2022. PMID: 35754070 Review.
-
The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations.Hepat Mon. 2014 Oct 11;14(10):e23539. doi: 10.5812/hepatmon.23539. eCollection 2014 Oct. Hepat Mon. 2014. PMID: 25477978 Free PMC article. Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Changing Prevalence of Medication Use in People with Cirrhosis: A Retrospective Cohort Study Using Pharmaceutical Benefits Scheme Data.Drugs Real World Outcomes. 2023 Dec;10(4):605-618. doi: 10.1007/s40801-023-00390-2. Epub 2023 Oct 13. Drugs Real World Outcomes. 2023. PMID: 37828144 Free PMC article.
-
Low back pain in patients hospitalised with liver cirrhosis- a retrospective study.BMC Musculoskelet Disord. 2023 Apr 19;24(1):310. doi: 10.1186/s12891-023-06424-8. BMC Musculoskelet Disord. 2023. PMID: 37076822 Free PMC article.
-
Palliative Care for Patients with End-Stage Liver Disease.J Clin Exp Hepatol. 2023 Mar-Apr;13(2):319-328. doi: 10.1016/j.jceh.2022.08.003. Epub 2022 Aug 13. J Clin Exp Hepatol. 2023. PMID: 36950499 Free PMC article. Review.
-
Future liver remnant volume is associated with postoperative fentanyl consumption following open donor hepatectomy: a retrospective multivariate analysis.J Anesth. 2022 Dec;36(6):731-739. doi: 10.1007/s00540-022-03110-2. Epub 2022 Oct 3. J Anesth. 2022. PMID: 36190573
-
Metamizole-Associated Risks in Decompensated Hepatic Cirrhosis.Dtsch Arztebl Int. 2022 Oct 14;119(41):687-693. doi: 10.3238/arztebl.m2022.0280. Dtsch Arztebl Int. 2022. PMID: 35912424 Free PMC article.
References
-
- Rogal SS, Bielefeldt K, Wasan AD, Lotrich FE, Zickmund S, Szigethy E, DiMartini AF. Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clinical Gastroenterology and Hepatology. 2015 May 31;13(5):1009–16. Prospective study highlighting the prevalence of pain and opioid use among patients with cirrhosis. - PMC - PubMed
-
- Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Journal of pain and symptom management. 2008 Jul 31;36(1):39–45. - PubMed
-
- Silberbogen AK, Janke EA, Hebenstreit C. A closer look at pain and hepatitis C: preliminary data from a veteran population. Journal of rehabilitation research and development. 2007 Feb 15;44(2):231. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials